| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |